Clinical Trial Update: A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of DXC008 in prostate cancer and other solid tumors is currently recruiting, with Ewing sarcoma among the listed conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Prostate Cancer

Drugs mentioned

• DXC008

Snippet

Sponsor: Hangzhou DAC Biotechnology Co., Ltd. | Conditions: Prostate Cancer, Other Solid Tumors | Phase 1 | Status: RECRUITING